FX Solutions, SAS. and FX Shoulder, Inc. to Merge into FX

Now One Global Brand with One Global Identity Focused on the Shoulder Arthroplasty Market

FX Solutions was founded in 2011 in Viriat, France, and there has always been a vision and passion to grow the portfolio to become a major global competitor. With its start in France, they quickly expanded their market presence throughout Europe.

In 2017, FX Solutions was acquired by Ekkio Capital (Paris, FR). This was the driving force to begin expansion into an extremely competitive US market. FX Shoulder USA was launched as a subsidiary of FX Solutions and quickly grew their footprint in the US Market. With many recent changes and innovations in the US, FX Shoulder has become one of the fastest growing and most innovative companies in its market segment. This was done by staying hyper-focused on shoulder arthroplasty—a market segment that continues to grow at an aggressive pace with constant innovation that allows surgeons even more solutions to care for patients.

“With a complete portfolio and with constant innovation, the time is now to join our two companies as one identity on the global stage,” said, Baptiste Martin, CEO of FX. “This will allow us to streamline our efforts and move as one team with one common goal—to grow our portfolio and market share globally with several key areas of opportunity.”

FX Shoulder USA, Inc. is the direct provider of FX Solutions shoulder replacement devices in the US. FX Solutions will continue to provide the portfolio and sales efforts worldwide (OUS). Both will now be branded as one company [FX] with a US Headquarters in Dallas, and a Global Headquarters in Viriat, France.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”